Brought to you by 
Amicus Therapeutics nets $69.75mm via IPO
16 Oct 2007
Executive Summary
Amicus Therapeutics (developing oral drugs to treat various genetic diseases) has netted $69.75mm in its initial public offering of 5mm shares for $15 each; the original anticipated range was between $14-16.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amicus Therapeutics nets $69.75mm via IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice